Nottinghamshire Insight

Pharmaceutical needs assessment

The aim of the Pharmaceutical Needs Assessment (PNA) is to enable understanding of the pharmaceutical needs of our local population and where necessary use this information to develop pharmaceutical services to meet any identified unmet needs. The PNA is used to inform the commissioning process in respect to pharmaceutical needs in Nottinghamshire.

A Supplementary Statement records changes to the provision of pharmacy services since the publication of the Pharmaceutical Needs Assessment. Supplementary Statements are issued for opening or closure of pharmacies or when there are pharmaceutical needs assessment changes that are minor and would be relevant for granting of applications. Once issued, a supplementary statement becomes part of the PNA.

Changes since then are recorded in supplementary statements and an up to date list of pharmacies will be published by Nottinghamshire Public Health with the supplementary statements each quarter, and will serve to update the PNA published in March 2018.

 

Supplementary Statements 2018/19

 

 

Supplementary Statements 2019/20

 

Supplementary Statements 2020/21

 

Supplementary Statements 2020/21

Please note that due to covid-19 pharmacies should be following the Standard Operating Procedures (SOP) guidance which advises pharmacies to reduce operating hours to maintain safety. Following this and other individual circumstances such a staff sickness, pharmacies opening hours are likely to be frequently changing during this current time and these supplementary statements will not be able to reflect this. During this time individual pharmacy websites are likely to provide the most up to date information regarding opening hours.

Update on the 2021-2024 PNA refresh 

 

Due to current pressures in response to the COVID-19 pandemic, the Department of Health and Social Care has announced that the requirement to publish renewed Pharmaceutical Need Assessments will be suspended until April 2022. Health and Wellbeing Boards will retain the ability to issue supplementary statements to respond to local changes and pharmaceutical needs during this time. The NHS Pharmaceutical and Local Pharmaceutical Services Regulations 2013 will be updated in due course.